Objectives: To discuss the metabolic syndrome and identify its risk factors, including in the pediatric age group.
and diabetes mellitus type 2.
1 During the 1980s, Reaven, 2 observed that dyslipidemia, arterial hypertension and hyperglycemia were very often found in combination in a single patient and that they indicated increased cardiovascular risk; a condition he named Syndrome X. Since then, many different definitions of metabolic syndrome have emerged. Consensus has not yet been reached on the diagnostic criteria for metabolic syndrome. Table 1 below compares the criteria from the leading institutions that have released publications on the subject.
In addition to these criteria, which are used to diagnose the metabolic syndrome, other metabolic abnormalities, such as increased fibrinogen and plasminogen activity factor, hyperuricemia, increased C-reactive protein, hyperhomocysteinemia, increased TNF-α expression and reduced adiponectin levels, are frequently present. 1 There is no definition of the metabolic syndrome in childhood that is accepted by the entire scientific community. 1 Cook et al. 3 adapted the NCEP criteria and proposed a definition of pediatric metabolic syndrome based on the presence of three out of the following criteria: waist circumference greater than or equal to the 90th percentile, fasting glycemia greater than or equal to 110 mg/dL, triglycerides greater than or equal to 110 mg/dL, HDL-cholesterol less than 40 mg/dL and arterial blood pressure greater than or equal to the 90th percentile. Furthermore, measurement of waist circumference in children is not standardized. Some authors have standardized measurements by age and define measurements above the 90th percentile as elevated.
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Pathophysiology
Epidemiological studies suggest that there is a relationship between low birth weight, especially in small for gestational age infants, and developing metabolic syndrome in adulthood. According to the World Health Organization, 5 low birth weight is the term that should be used to describe infants born weighing less than 2,500 grams. The definition of small for gestational age (SGA), has greater scope and takes into consideration weight and length, according to sex and gestational age. 6 Infants born below -2 standard deviations are defined as SGA, which makes it easier to identify in newborns who have been affected by some degree of fetal suffering. It is estimated that 2.3% to 10% of newborn infants are SGA.
The majority of these children manage to attain normal growth within the first 2 years of life, known as catch-up growth. Being SGA brings with it a risk of metabolic syndrome in adulthood, especially for those children who recover rapidly soon after birth. In contrast, absence of catch-up growth is a cause of short stature and many psychological consequences during adolescence and adulthood. 7 The causative mechanisms of the relationship between SGA and the metabolic syndrome remain obscure, but, currently, the hypothesis of fetal programming, by which fetal adaptation to exposure to nutrient scarcity results in a failure to adapt to exposure to an abundance of nutrients, is widely accepted. 8, 9 This hypothesis, also known as the Barker Hypothesis, 10 postulates that certain structures of the organs have their functions programmed during embryonic and fetal life. This programming will determine the balance (set point)
of adult physiological and metabolic responses. 8 Barker et al.
found that the prevalence of insulin resistance at 50 years of age was 10 times greater among individuals who had been born weighing less than 2.5 kg.
In contrast, Neel 11 therefore, further studies are needed. 7 It is imperative that these studies employ standardized methods to assess gestational age, such as ultrasound. 13 This environment causes changes to metabolism, the immune system, the vascular system, hemodynamics, the renal system and growth. Some authors believe that increased oxidative stress suffered in these situations is directly related to modulation of genes related to the action of insulin and modulation of arterial blood pressure, and, therefore, may be one of the mechanisms behind the emergence of the metabolic syndrome in adulthood. 14 Infants born at high weights are also at increased risk of metabolic syndrome, although for low birth weight babies the risk is much greater. There are currently several ongoing prospective and randomized studies attempting to prevent oxidative stress during gestation. 
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Newborn infants subjected to a hyperinsulinemic uterine environment also exhibit an increased risk of developing metabolic syndrome in adulthood. Boney et al. 16 assessed the development of metabolic syndrome in individuals who were large for gestational age (LGA) and appropriate for gestational age (AGA). The study followed-up 84 children in the LGA group and 95 in the AGA group, at ages 6, 7, 9 and 11 years, the mothers of whom did or did not have a history of gestational diabetes. The children were subdivided into four groups:
LGA with control mothers, LGA with mothers with gestational DM, AGA with control mothers and AGA with mothers with gestational DM. Anthropometric and biometric measurements were taken at 6, 7, 9 and 11 years. Metabolic syndrome -Lottenberg SA et al.
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the age group from 20 to 29 years, 43.5% for 60 to 69 years and 42% among those more than 70 years old. 18 Although it is more common among the elderly, the incidence rate of metabolic syndrome at earlier ages has been increasing, especially due to lifestyle changes and the increase in obesity. 19 The prevalence of metabolic syndrome among American adolescents is 4.8%, varying depending on age, sex, ethnic origin, social strata and presence of obesity. 
Treatment
Weight loss has a major impact on the metabolic syn-
drome. Published data demonstrate that a reduction of 7% to 10% of initial weight is enough to provoke improvements in waist circumference, lipid profile and glycemia. 26 It is of fundamental importance to treat childhood obesity, and, in order that this treatment is successful, it is fundamental to involve the child/adolescent, their family and their social environment, in order to encourage lifestyle changes.
Changes aimed at achieving healthy diet must be embarked on by the entire family, with the intention of increasing the consumption of fruit, vegetables, skimmed milk products and water, two fraction feeding and reduce consumption of fried food, pastries, sweets and processed meat products.
Promotion of physical activity, whether programmed or not, reducing the child's idle time, especially in front of the television and computer, is another crucial point. The entire family should also be involved in this process.
In pediatrics, pharmacological treatment of obesity should be restricted to cases that are most resistant to clinical treatment and of the greatest severity. In the United States, only sibutramine and orlistat have been approved, for use with children over 12 years of age.
Metformin is indicated for children with glucose intolerance or diabetes mellitus type 2. In these patients the drug has an anorexigenic effect, reducing glucose and insulin levels and improving the lipid profile. 27 Hypertension and dyslipidemia should also be treated with lifestyle changes and drugs, depending on the severity of the case.
Bariatric surgery for the treatment of adolescent obesity is an extremely invasive procedure and it can only be indicated in extremely restricted circumstances in this age group.
The American Pediatric Surgical Association Clinical Task Force on Bariatric Surgery recommends that adolescents may be candidates for the procedure if they have a BMI greater than 50, or greater than 40 and associated with comorbidities (sleep apnea, diabetes mellitus type 2), are at a minimum Tanner puberty stage of III, a multidisciplinary team has failed to achieve a response after at least 6 months' treatment, medical and psychological assessments have been completed, there are severe problems socializing, there is good family support and if they are over 13 years old and have the capacity to take informed decisions. 28 In summary, treatment and prevention of childhood obesity have become a public health priority. Acquisition of excessive fat during the postnatal period is related to insulin resistance in adulthood and breastfeeding may prevent this obesity. 7 Appropriate nutrition and increase physical activity, while still in childhood, are, therefore, important elements in prevention of the metabolic syndrome and, consequently of cardiovascular diseases in adulthood.
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